Sarepta Therapeutics Appoints Gilmore O'Neill, M.B., M.M.Sc. as Chief Medical Officer

Author's Avatar
Jun 07, 2018
Article's Main Image

-- Dr. O’Neill joins Sarepta from Biogen, where he served as senior vice president of late-stage clinical development, including Spinraza® for spinal muscular atrophy (SMA); brings deep clinical experience in neurology, rare disease and gene therapy --